Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
Honduras signs an agreement with Pfizer and BioNTech to purchase additional 2.7 million doses of the Pfizer-BioNTech COVID-19 vaccine in order to ensure the country will have enough supply to vaccinate all people over the age of 12 this year. 2021-08-26
Prime Minister Justin Trudeau says Pfizer will double the amounts of vaccine that are being shipped to Canada. He also announces that the Canadian Red Cross will be deployed to Ontario to help with COVID-19 vaccinations. 2021-04-16
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Serbia officially begins its vaccination programme against COVID-19, with Prime Minister Ana Brnabić becoming the first person to receive the Pfizer-BioNTech vaccine. 2020-12-24
Switzerland begins a mass vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine tozinameran. A ninety-year-old woman in Lucerne is the first Swiss citizen to receive the vaccine. 2020-12-23
Singapore receives the Pfizer-BioNTech vaccine, becoming the first country in Asia to do so. 2020-12-21
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
Pfizer and BioNTech say that their potential vaccine is 90% effective at preventing COVID-19 infections. 2020-11-9
American company Pfizer and German company BioNTech say that they are on track to being submitted for regulatory review as early as October. 2020-08-21